BASF Valuation

Is BASD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BASD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: BASD (€47.15) is trading below our estimate of fair value (€105.87)

Significantly Below Fair Value: BASD is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for BASD?

Other financial metrics that can be useful for relative valuation.

BASD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1x
Enterprise Value/EBITDA11.9x
PEG Ration/a

Price to Sales Ratio vs Peers

How does BASD's PS Ratio compare to its peers?

The above table shows the PS ratio for BASD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.8x
AAL Anglo American
1.2x2.1%UK£27.9b
GLEN Glencore
0.3x-0.9%UK£51.3b
ANTO Antofagasta
3.9x8.3%UK£18.9b
RIO Rio Tinto Group
2x-0.4%UK£86.4b
BASD BASF
0.6x4.4%€42.2b

Price-To-Sales vs Peers: BASD is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (1.8x).


Price to Earnings Ratio vs Industry

How does BASD's PE Ratio compare vs other companies in the GB Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a28.8%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a28.8%
n/an/an/a
No more companies

Price-To-Sales vs Industry: BASD is good value based on its Price-To-Sales Ratio (0.6x) compared to the UK Chemicals industry average (1.4x).


Price to Sales Ratio vs Fair Ratio

What is BASD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BASD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.6x
Fair PS Ratio1.6x

Price-To-Sales vs Fair Ratio: BASD is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (1.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst BASD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€47.15
€52.55
+11.5%
12.5%€65.00€42.00n/a20
Oct ’25€47.06
€52.25
+11.0%
13.0%€65.00€42.00n/a20
Sep ’25€45.03
€53.21
+18.2%
13.7%€70.00€42.00n/a19
Aug ’25€42.75
€53.84
+25.9%
13.1%€70.00€42.00n/a19
Jul ’25n/a
€54.74
0%
12.9%€72.00€43.00n/a19
Jun ’25€48.30
€55.74
+15.4%
12.1%€72.00€43.00n/a19
May ’25€49.18
€55.68
+13.2%
12.1%€72.00€43.00n/a19
Apr ’25€53.08
€52.70
-0.7%
13.3%€63.00€41.00n/a20
Mar ’25€47.54
€50.15
+5.5%
13.3%€62.00€39.00n/a20
Feb ’25€44.15
€48.89
+10.8%
13.8%€62.00€39.00n/a19
Jan ’25€48.58
€50.26
+3.5%
12.1%€62.00€39.00n/a19
Dec ’24€42.84
€48.98
+14.3%
13.7%€62.00€39.00n/a21
Nov ’24€43.54
€49.12
+12.8%
13.1%€62.00€37.00n/a21
Oct ’24€42.87
€50.90
+18.7%
13.4%€64.00€37.00€47.0621
Sep ’24€47.14
€51.32
+8.9%
12.3%€64.00€40.00€45.0321
Aug ’24€49.33
€51.46
+4.3%
12.2%€64.00€40.00€42.7521
Jul ’24€44.30
€53.61
+21.0%
15.1%€75.00€43.00n/a22
Jun ’24€44.76
€54.05
+20.8%
17.0%€75.00€31.03€48.3022
May ’24€46.79
€53.86
+15.1%
16.5%€72.00€31.03€49.1822
Apr ’24€48.03
€53.77
+12.0%
16.0%€68.00€31.03€53.0822
Mar ’24€48.35
€54.14
+12.0%
15.6%€68.00€31.03€47.5422
Feb ’24€52.78
€53.50
+1.4%
15.7%€68.00€31.03€44.1522
Jan ’24€46.64
€53.84
+15.5%
17.2%€72.00€31.03€48.5823
Dec ’23€47.87
€54.06
+12.9%
18.0%€75.00€31.03€42.8423
Nov ’23€45.39
€53.20
+17.2%
17.3%€75.00€31.03€43.5423
Oct ’23€39.51
€54.61
+38.2%
20.3%€80.00€31.03€42.8723

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies